Published in
Molecular-Guided Surgery: Molecules, Devices, and Applications VI, 2020
DOI: 10.1117/12.2546190
Links
Tools
A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery
Proceedings article published in 2020 by
Servando Hernandez Vargas 
,
Christie Lin,
Solmaz Agha Amiri,
Julie Voss,
Naru Ikoma,
Hop S. Tran Cao,
Sukhen C. Ghosh,
Adam Uselmann,
Ali Azhdarinia
,
Christie Lin,
Solmaz Agha Amiri,
Julie Voss,
Naru Ikoma,
Hop S. Tran Cao,
Sukhen C. Ghosh,
Adam Uselmann,
Ali Azhdarinia
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Data provided by 